SBMC, High Tech NL, and BOM join forces for biomedical innovation
Smart BioMaterials Consortium (SBMC), High Tech NL, and the Brabant Development Agency (BOM) are collaborating to accelerate innovations in regenerative medicine. Juliette van den Dolder has been appointed as an Innovation Designer with the goal of accelerating the development of production technology for regenerative therapies and connecting the SBMC ecosystem with the NXTGEN Hightech program ‘biomedical production technology’, supported by High Tech NL.
“Scaling up and bringing regenerative therapies to market cannot be done without the right production technology,” says Jan Rietsema, director of SBMC. “One expertise lies with SBMC, the other with NXTGEN Hightech. Therefore, it is crucial that the ecosystems around both organizations can complement each other well. The new partnership is also good news for companies like LifeTec Group, Vivolta, Stentit, and Xeltis that are already collaborating with SBMC and NXTGEN Hightech.”
“We see that companies within our current ecosystem already know how to find each other well, and this has tremendous added value,” says Ingrid Relou, domain leader Biomedical Production Technology at NXTGEN Hightech. “The collaboration with SBMC contributes to the development of even better and more widely applicable production technologies.”
“The new collaboration aims to increase the earning capacity of the Netherlands,” says Willem Endhoven, director of High Tech NL. “This aligns well with the goal of the National Growth Fund, the main funder of SBMC and NXTGEN Hightech.”
“With the embedding of the facilitator role at BOM, we are happy to contribute to the project with our knowledge and network,” says Chantal Dietvorst, Managing Director Ecosystems Development at BOM. “Both ecosystems have a strong foothold in Brabant. By strengthening innovation ecosystems and connecting various parties, we ensure that new innovations and business can progress even faster.”